Author:
Han Huamin,He Wen,Wang Wei,Gao Bin
Abstract
Abstract
Background
Acquired immunodeficiency syndrome (AIDS), which is caused by the human immunodeficiency virus (HIV), is an immunosuppressive disease that results in life-threatening opportunistic infections. The general problems in current therapy include the constant emergence of drug-resistant HIV strains, adverse side effects and the unavailability of treatments in developing countries. Natural products from herbs with the abilities to inhibit HIV-1 life cycle at different stages, have served as excellent sources of new anti-HIV-1 drugs. In this study, we aimed to investigate the anti-HIV-1 activity of aqueous dandelion extract.
Methods
The pseudotyped HIV-1 virus has been utilized to explore the anti-HIV-1 activity of dandelion, the level of HIV-1 replication was assessed by the percentage of GFP-positive cells. The inhibitory effect of the dandelion extract on reverse transcriptase activity was assessed by the reverse transcriptase assay kit.
Results
Compared to control values obtained from cells infected without treatment, the level of HIV-1 replication and reverse transcriptase activity were decreased in a dose-dependent manner. The data suggest that dandelion extract has a potent inhibitory activity against HIV-1 replication and reverse transcriptase activity. The identification of HIV-1 antiviral compounds from Taraxacum officinale should be pursued.
Conclusions
The dandelion extract showed strong activity against HIV-1 RT and inhibited both the HIV-1 vector and the hybrid-MoMuLV/MoMuSV retrovirus replication. These findings provide additional support for the potential therapeutic efficacy of Taraxacum officinale. Extracts from this plant may be regarded as another starting point for the development of an antiretroviral therapy with fewer side effects.
Publisher
Springer Science and Business Media LLC
Subject
Complementary and alternative medicine,General Medicine
Reference41 articles.
1. Cohen J: AIDS research. Promising AIDS vaccine's failure leaves field reeling. Science. 2007, 318: 28-29. 10.1126/science.318.5847.28.
2. Shafer RW, Schapiro JM: HIV-1 drug resistance mutations: an updated framework for the second decade of HAART. AIDS Rev. 2008, 10: 67-84.
3. Vo TS, Kim SK: Potential Anti-HIV Agents from Marine Resources: An Overview. Mar Drugs. 2010, 8: 2871-2892. 10.3390/md8122871.
4. Jiang Y, Ng TB, Wang CR, Zhang D, Cheng ZH, Liu ZK, Qiao WT, Geng YQ, Li N, Liu F: Inhibitors from natural products to HIV-1 reverse transcriptase, protease and integrase. Mini Rev Med Chem. 2010, 10: 1331-1344. 10.2174/138955710793564133.
5. Filho JR, de Sousa Falcao H, Batista LM, Filho JM, Piuvezam MR: Effects of plant extracts on HIV-1 protease. Curr HIV Res. 2010, 8: 531-544. 10.2174/157016210793499204.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Botany, Traditional Use, Phytochemistry, Pharmacology and Quality Control of Taraxaci herba: Comprehensive Review;Pharmaceuticals;2024-08-23
2. Farklı Çözücülerde Ekstrakte Edilen Taraxacum officinale Ekstraktlarının Bacteroides fragilis ATCC 25285 Standart Suşu Üzerindeki Antibakteriyel Etkisinin Sıvı Mikrodilüsyon Yöntemiyle Araştırılması;Mikrobiyoloji Bulteni;2024-01-22
3. Phenolic, tocopherol, and essential fatty acid-rich extracts from dandelion seeds: Chemical composition and biological activity;Food and Bioproducts Processing;2023-11
4. Chinese herbal extracts with antiviral activity: evaluation, mechanisms, and potential for preventing PRV, PEDV and PRRSV infections;Animal Diseases;2023-10-26
5. Effect of Chinese herbal medicine therapy on risks of all-cause mortality, infections, parasites, and circulatory-related mortality in HIV/AIDS patients with neurological diseases;Frontiers in Pharmacology;2023-03-03